Stay updated on AK104 in NSCLC Phase II Clinical Trial
Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.
Latest updates to the AK104 in NSCLC Phase II Clinical Trial page
- Check4 days agoChange DetectedRevision v3.3.4 was added to the Record History.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check54 days agoChange DetectedAn entry for revision v3.3.2 was added to the history. The previously listed revision v3.2.0 was removed.SummaryDifference0.1%
- Check61 days agoChange DetectedThe lapse in government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%
- Check76 days agoChange DetectedThe version history shows updates to recruitment status (and study status) for the AK104 trial in advanced non-small cell lung cancer on 2022-03-24 and 2025-03-10, with the latest entry indicating the current recruitment status.SummaryDifference0.1%
- Check104 days agoChange DetectedVersion bump to v3.2.0 accompanied by a government-operating-status notice; replaces v3.1.0.SummaryDifference13%
Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.